Platelet Reactivity in Acute Non-disabling Cerebrovascular Events
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 675 participants.
Also called NCT02506140
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 675 participants
- Registry
-
NCT02506140
-
- Other papers using this trial's data
- Impact of smoking on platelet function of ticagrelor versus clopidogrel in minor stroke or transient ischaemic attack
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT02506140. Randomized; single masking; primary purpose treatment. Start 2015-08 (registry gives no type); primary completion 2017-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Platelet Reactivity in Acute Non-disabling Cerebrovascular Events
- Acronym
- PRINCE
- Condition
- Stroke
- Condition
- Ischemic Attack, Transient
- Intervention (Drug)
- Ticagrelor and Acetylsalicylic acid
- Intervention (Drug)
- Clopidogrel and Acetylsalicylic acid
- Lead sponsor
- Beijing Tiantan Hospital
- Collaborator
- Beijing Municipal Science & Technology Commission
Record details
- Record id
cardio:ct-nct02506140- Content hash
b138978862e339bb0396b37c94ff34347e78d5eecafdcc1ccf81cbcd1bd6bafb